Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 33.60M | 27.88M | 19.25M | 39.33M | 27.88M | 31.23M |
Gross Profit | 7.04M | 7.83M | -7.18M | -6.77M | -342.89K | 2.75M |
EBITDA | 5.49M | 5.04M | -9.06M | -11.87M | -4.08M | 1.93M |
Net Income | 5.25M | 4.77M | -10.02M | -10.89M | -3.21M | 1.16M |
Balance Sheet | ||||||
Total Assets | 40.04M | 28.05M | 17.92M | 24.10M | 28.77M | 23.07M |
Cash, Cash Equivalents and Short-Term Investments | 15.29M | 8.84M | 1.00M | 3.12M | 13.07M | 17.43M |
Total Debt | 17.93M | 9.07M | 7.26M | 2.63M | 2.78M | 788.00K |
Total Liabilities | 27.61M | 19.28M | 15.75M | 12.21M | 12.50M | 4.47M |
Stockholders Equity | 12.44M | 8.77M | 2.17M | 11.88M | 16.27M | 18.60M |
Cash Flow | ||||||
Free Cash Flow | -190.81K | 6.89M | -6.80M | -15.21M | -2.59M | 2.42M |
Operating Cash Flow | 961.77K | 7.24M | -5.36M | -11.77M | 156.59K | 3.59M |
Investing Cash Flow | -5.18M | -3.92M | -1.44M | -3.44M | -4.49M | -1.17M |
Financing Cash Flow | 10.57M | 915.22K | 4.68M | 5.26M | 14.49M | -793.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | AU$15.54M | 10.38 | 22.25% | ― | 10.55% | 116.67% | |
69 Neutral | AU$21.86M | 6.56 | 30.50% | ― | 15.59% | ― | |
67 Neutral | $16.55B | 16.99 | 4.47% | 3.56% | 4.76% | 6.17% | |
62 Neutral | AU$37.45M | 6.79 | 63.00% | ― | 333.36% | ― | |
56 Neutral | AU$19.77M | ― | -12.02% | ― | 69.91% | -89.19% | |
34 Underperform | AU$17.55M | ― | -157.90% | ― | ― | -390.90% | |
26 Underperform | AU$4.96M | ― | -32.27% | ― | ― | -26.37% |
Delorean Corporation Ltd has announced significant regulatory changes in Australia that enhance the viability of its biomethane projects. The amendments to the Australian Standards and the National Greenhouse Energy and Reporting (NGER) Scheme recognize biomethane as a natural gas equivalent, allowing companies to use Renewable Gas Guarantee of Origin (RGGO) certificates to reduce emissions. These changes are expected to improve Delorean’s project timelines, reduce costs, and provide greater market certainty, positioning the company to accelerate its commercial project rollout and capitalize on new opportunities.
Delorean Corporation Ltd, a company listed on the ASX, announced a change in its company secretary position. Aidan Flynn, who is also the Chief Financial Officer, has been appointed as the new Company Secretary, succeeding David McArthur. McArthur will continue to serve as a Non-Executive Director. Flynn brings extensive financial and ASX experience to his new role, which is expected to enhance the company’s governance and communication with the ASX.
Delorean Corporation Limited has made significant strides in its transition to renewable gas production, highlighted by the connection of its SA1 Salisbury Bioenergy plant to the Australian Gas Infrastructure Group’s gas grid for biomethane distribution. The company has also secured agreements for the sale of biogenic liquid carbon dioxide and additional funding to support its projects. Key developments include progress on the Yarra Valley Water food waste to energy project and the ongoing co-development of the NSW1 project with Brickworks Building Products. These initiatives underscore Delorean’s commitment to expanding its renewable energy footprint and meeting the growing demand for renewable gas and CO2.
Delorean Corporation Limited announced the cessation of 1,000,000 securities, specifically options expiring on November 30, 2028, with an exercise price of $0.19. This development may impact the company’s capital structure and could have implications for its financial strategy and stakeholder interests.
Delorean Corporation Limited has announced the issuance of 4,000,000 new unquoted equity securities in the form of options. These options are exercisable at 18.4 cents and will expire on September 13, 2028. This move is part of Delorean’s strategic financial operations, potentially impacting its capital structure and providing new opportunities for investors.
Delorean Corporation Ltd has secured $7 million in debt funding to upgrade and expand its SA1 bioenergy plant, complementing previous funding from ARENA and existing debt. This funding ensures the plant is fully financed, allowing Delorean to produce six different monetization streams, including renewable natural gas and food-grade LCO2. The expansion supports a significant 10-year offtake agreement with Supagas, expected to boost net profitability by $15-25 million. The project, with a construction cost of approximately $36 million, underscores Delorean’s strategic positioning in the bioenergy sector and its commitment to sustainable energy solutions.